Can you get medical cannabis for Parkinson's disease in the UK?
Parkinson's disease is considered by UK specialists in selected cases, and the important detail is which symptoms. The trial evidence points to non-motor symptoms — anxiety and sleep — rather than to tremor or stiffness, which is the opposite of what most people expect.
The short answer
- It is considered in selected cases only, and no product is licensed for Parkinson's in the UK.
- The trial signal is in non-motor symptoms — anxiety and night-time sleep — not motor symptoms.
- It does not replace levodopa or any other Parkinson's medication, and does not slow the disease.
- Falls, blood pressure and confusion are specific risks that weigh heavily in Parkinson's.
- Your neurology team should stay involved, since Parkinson's medicines are finely balanced.
Is Parkinson's disease treated with medical cannabis in the UK?
It is assessed in selected cases by private specialists, and it is not an NHS treatment for Parkinson's. Nothing is licensed for it, and NICE guideline NG71 on Parkinson's does not recommend cannabis-based medicines.
Where it is considered, the target is usually a specific troublesome symptom rather than the disease as a whole. In practice that means the non-motor symptoms that respond poorly to dopaminergic treatment: anxiety, disturbed night-time sleep, pain, and sometimes nausea. Motor symptoms — tremor, rigidity, bradykinesia — are managed with levodopa and related medicines, and there is no good evidence that a cannabis-based medicine improves them.
Parkinson's medicines are timed and titrated carefully, and small changes have large effects. Nothing on this page should be added, changed or stopped without your Parkinson's specialist or nurse being part of the decision.
What the evidence actually shows
The best-designed study in Parkinson's used a synthetic cannabinoid rather than a plant-derived product, and found a modest effect on non-motor symptoms rather than motor ones.
The NMS-Nab study was a randomised, placebo-controlled, double-blind trial with an enriched enrolment randomised withdrawal design, testing nabilone for non-motor symptoms in Parkinson's disease. It reported a significant advantage for nabilone on the MDS-UPDRS Part I score, with the effect driven mainly by improvements in anxious mood and night-time sleep problems. It was a small study, in a selected group of responders, over a short period.
Beyond that, evidence in Parkinson's is largely observational or from studies too small to draw conclusions from. Cannabidiol has been studied for Parkinson's-related psychosis and anxiety in early trials, without results that have changed practice.
The study behind that paragraph
Peball M, Werkmann M, Ellmerer P, et al. Nabilone for non-motor symptoms of Parkinson's disease: a randomized placebo-controlled, double-blind, parallel-group, enriched enrolment randomized withdrawal study (NMS-Nab study). Journal of Neural Transmission. 2019;126(8):1061-1072. A small randomised withdrawal trial showing benefit on non-motor symptoms, driven mainly by anxious mood and night-time sleep.
What a specialist will want to see
There is no UK list of qualifying conditions, so nothing here entitles you to a prescription. A specialist works through your history and decides whether a monitored trial is justified for you. For Parkinson's disease they will typically look at:
- How long you have had Parkinson's, and who manages your treatment
- Which symptom you actually want addressed — anxiety, sleep, pain, nausea — rather than Parkinson's as a whole
- Your current medication regimen and timings, since these are easily destabilised
- Whether you have had hallucinations, delusions or confusion, which change the risk calculation substantially
- Your blood pressure, including postural drops, and your falls history
- Cognitive changes, which are common in Parkinson's and can be worsened by THC
The general requirements — age, a documented diagnosis, the convention that two standard treatments have been tried, and access to your medical records — are covered in What are the requirements?
Risks and reasons a specialist may say no
Parkinson's carries specific risks that make this a more cautious decision than in most conditions. Postural hypotension and falls are common already, and dizziness and sedation add to both.
Hallucinations and confusion occur in Parkinson's, particularly in later stages and with some Parkinson's medicines. THC can precipitate or worsen them, and a history of Parkinson's-related psychosis would normally rule out THC-containing treatment. Cognitive impairment is a further consideration. A specialist will want your Parkinson's team involved rather than prescribing in parallel, because the interaction with your existing regimen matters more than the medicine alone.
If you want to take this further
The useful next step is a proper assessment, not a better list. Gather your diagnosis, the treatments you have already tried and what happened with each, and your current medicines — that is what a specialist needs in order to give you a straight answer.
The consultation itself, and what happens after it, is set out in What is the process to get a medical cannabis prescription? If Parkinson's disease is not the only thing you are being treated for, say so early: other conditions and other medicines change the assessment.
Frequently asked questions
Can I get medical cannabis for Parkinson's in the UK?
It is considered in selected cases by private specialists, usually for a specific non-motor symptom rather than for Parkinson's as a whole. Nothing is licensed for Parkinson's in the UK, and NICE guideline NG71 does not recommend cannabis-based medicines for it.
Does it help tremor?
There is no good evidence that it does. The best trial evidence in Parkinson's concerns non-motor symptoms — anxiety and night-time sleep — not tremor, rigidity or slowness of movement. Those remain the job of levodopa and related medicines.
Can it replace my Parkinson's medication?
No. It is not disease-modifying and does not substitute for dopaminergic treatment. Parkinson's regimens are finely balanced and should only be changed by your Parkinson's specialist or nurse.
Why are hallucinations a particular concern?
Hallucinations and confusion are recognised features of Parkinson's, especially in later stages and with some Parkinson's medicines. THC can trigger or worsen them, so a history of Parkinson's-related psychosis normally rules out THC-containing treatment.
Sources and further reading
Every factual statement on this page is drawn from the following public sources. Links open in a new tab and are not affiliated with Flora House.
- Peball M, et al. Nabilone for non-motor symptoms of Parkinson's disease: a randomized placebo-controlled, double-blind, parallel-group, enriched enrolment randomized withdrawal study. Journal of Neural Transmission (2019)
- NICE guideline NG71: Parkinson's disease in adults
- NHS: Parkinson's disease
- NICE guideline NG144: Cannabis-based medicinal products
- NHS: Medical cannabis (and cannabis oils)
- House of Commons Library briefing CBP-8355: Medical use of cannabis
- MHRA: The supply, manufacture, importation and distribution of unlicensed cannabis-based products for medicinal use